Stifel Nicolaus is upgrading iStar Financial SFI to Buy.
It is also upgrading Newcastle Investment NCT to Buy.
It is increasing the target price on Endo Pharmaceuticals ENDP to $53.00 from $45.00.
Estimates are increased on iStar Financial and Newcastle Investment, and coverage is discontinued on Tree.com TREE.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Analyst ColorUpgradesPrice TargetAnalyst Ratingsendo pharmaceuticalsFinancialsHealth CareiStar Financial Inc. (SFI)Mortgage REIT'snewcastle investmentPharmaceuticalsStifel NicolausThrifts & Mortgage Financetree.com
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
